DILLON & ASSOCIATES INC - Q1 2020 holdings

$297 Million is the total value of DILLON & ASSOCIATES INC's 64 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .

 Value Shares↓ Weighting
NEE  NextEra Energy Inc.$1,349,000
-0.4%
5,5970.0%0.45%
+19.8%
AMGN  Amgen$607,000
-15.7%
2,9890.0%0.20%
+1.5%
K  Kellogg$505,000
-13.1%
8,4200.0%0.17%
+4.3%
BMY  Bristol-Myers Squibb$318,000
-12.6%
5,6840.0%0.11%
+4.9%
ETN  Eaton Corp. PLC$284,000
-17.9%
3,6460.0%0.10%
-1.0%
UNH  UnitedHealth Group Inc.$274,000
-15.2%
1,1000.0%0.09%
+2.2%
TGT  Target Corp.$270,000
-27.2%
2,9000.0%0.09%
-12.5%
NEO  Neogenomics Inc$224,000
-3.4%
8,0000.0%0.08%
+15.4%
RMTI  Rockwell Medical Tech Inc$23,0000.0%11,4940.0%0.01%
+33.3%
CLSN  Celsion Corp New$20,000
-55.6%
22,3530.0%0.01%
-46.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-07
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Apple, Inc.42Q3 202311.9%
Stryker42Q3 20236.3%
Visa Inc.42Q3 20236.5%
Abbott Labs42Q3 20235.7%
Automatic Data Processing42Q3 20234.8%
PepsiCo42Q3 20234.9%
Colgate-Palmolive42Q3 20235.9%
Paychex42Q3 20234.3%
Air Products42Q3 20233.7%
Lowe's42Q3 20233.9%

View DILLON & ASSOCIATES INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-04-30
13F-HR2024-02-08
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR/A2023-05-02
13F-HR2023-05-01
13F-HR2023-02-06
13F-HR2022-11-08
13F-HR2022-07-26
13F-HR2022-05-06

View DILLON & ASSOCIATES INC's complete filings history.

Compare quarters

Export DILLON & ASSOCIATES INC's holdings